CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: kidney OR renal OR nephrotoxic
2 - 2 of 512 Bibliographic entries
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.
Back to Results
Titanium dioxide nanoparticles: a review of current toxicological data.
Authors
Shi-H; Magaye-R; Castranova-V; Zhao-J
Source
Part Fibre Toxicol 2013 Apr; 10:15
Link
http://dx.doi.org/10.1186/1743-8977-10-15 
NIOSHTIC No.
20042449 
Abstract
Titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide in large quantities for use in a wide range of applications. TiO2 NPs possess different physicochemical properties compared to their fine particle (FP) analogs, which might alter their bioactivity. Most of the literature cited here has focused on the respiratory system, showing the importance of inhalation as the primary route for TiO2 NP exposure in the workplace. TiO2 NPs may translocate to systemic organs from the lung and gastrointestinal tract (GIT) although the rate of translocation appears low. There have also been studies focusing on other potential routes of human exposure. Oral exposure mainly occurs through food products containing TiO2 NP-additives. Most dermal exposure studies, whether in vivo or in vitro, report that TiO2 NPs do not penetrate the stratum corneum (SC). In the field of nanomedicine, intravenous injection can deliver TiO2 nanoparticulate carriers directly into the human body. Upon intravenous exposure, TiO2 NPs can induce pathological lesions of the liver, spleen, kidneys, and brain. We have also shown here that most of these effects may be due to the use of very high doses of TiO2 NPs. There is also an enormous lack of epidemiological data regarding TiO2 NPs in spite of its increased production and use. However, long-term inhalation studies in rats have reported lung tumors. This review summarizes the current knowledge on the toxicology of TiO2 NPs and points out areas where further information is needed.
Keywords
Nanotechnology; Chemical-properties; Particulates; Respiration; Pulmonary-system; Pulmonary-system-disorders; Respiratory-system-disorders; Reticuloendothelial-system-disorders; Exposure-levels; Workers; Work-environment; Lung-function; Lung; Gastrointestinal-system; Pathology; Liver; Liver-function; Spleen-disorders; Kidneys; Kidney-disorders; Brain-disorders; Brain-function; Epidemiology; Lung-lesions; Tumors; Toxicology; Carcinogens; Carcinogenicity; Author Keywords: Titanium dioxide; Nanoparticle; Toxicology; Toxicokinetics; Acute toxicity; Chronic toxicity; Genotoxicity; Reproductive toxicity; Carcinogenicity
CAS No.
13463-67-7
Publication Date
20130401
Document Type
Journal Article
Email Address
583179597@qq.co
Fiscal Year
2013
NTIS Accession No.
NTIS Price
Identifying No.
B20130502
ISSN
1743-8977
NIOSH Division
HELD
Source Name
Particle and Fibre Toxicology
State
WV
Page 2 of 512

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.